| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |